Gene therapy could treat chronic hypereosinophilia
A study published in Human Gene Therapy has involved the generation of a human monoclonal antibody (mAb) directed against ...
CRISPR therapy corrects muscular dystrophy mutations and regrows muscles in mice
Researchers at the Experimental and Clinical Research Center (ECRC), a joint institution of the Max Delbrück Center and ...
Wayne biotech firm received $67.5 million investment to test gene therapy for heart disease
XyloCor Therapeutics Inc., a Wayne gene therapy company, received $67.5 million from investors to support Phase 2 trials of a treatment designed to grow new blood vessels in the heart, XyloCor ...
MyChesCo on MSN20h
Interius BioTherapeutics Expands Groundbreaking Gene Therapy Trial to Europe
Interius BioTherapeutics has secured approval from Germany’s Paul Ehrlich Institute (PEI) to expand its pioneering INVISE ...